Tiziana Life Sciences (LON:TILS) Stock Price Passes Below 200-Day Moving Average of $58.50

Tiziana Life Sciences PLC (LON:TILS)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 58.50 ($0.77) and traded as low as GBX 45 ($0.59). Tiziana Life Sciences shares last traded at GBX 58.50 ($0.77), with a volume of 297,127 shares changing hands.

Tiziana Life Sciences Stock Performance

The company’s fifty day simple moving average is GBX 58.50 and its 200 day simple moving average is GBX 58.50. The stock has a market capitalization of £113.85 million and a P/E ratio of -3.59. The company has a current ratio of 6.54, a quick ratio of 6.41 and a debt-to-equity ratio of 2.36.

Tiziana Life Sciences Company Profile

Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. Its product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as GvHD, ulcerative colitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma.